Biologics

Ascletis Advances ASC36 Oral Amylin Tablet With Strong Preclinical Weight Loss Data

Utilizing Ascletis' Peptide Oral Transport ENhancement Technology (POTENT), ASC36 oral tablets achieved absolute oral bioavailability of 6% to 8% at steady...

 February 12, 2026 | News

AsymBio Builds Integrated End To End Platforms To Accelerate Biopharmaceutical Development

AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ / 6821.HK), announced that it has established integrated technology platforms span...

 February 12, 2026 | News

Helix Partners With Mawi DNA To Broaden Access To Non Invasive Genomic Sample Collection

 Helix, the leading enterprise genomics company, has partnered with Mawi DNA Technologies, a leader in DNA sample collection and storage, to expa...

 February 12, 2026 | News

SOPHiA GENETICS Expands US Footprint With Two Major Health System Partnerships

SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, announced the addition of two of the largest U.S. healthcare systems ...

 February 12, 2026 | News

Made Scientific And Streamline Bio Launch Exclusive AI Driven Early Adopter Programme For GMP Ready Cell Therapy Manufacturing

Made Scientific, a leading clinical- and commercial-enabling cell therapy contract development and manufacturing organization (CDMO), and Streamline Bio, I...

 February 12, 2026 | News

Everest Medicines Licenses First In Class SHPT Therapy MT1013 From Micot For China And Asia Pacific

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, a...

 February 10, 2026 | News

Eisai And Henlius Sign Exclusive Japan Commercialisation Deal For Anti PD 1 Antibody Serplulimab

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Shanghai Henlius Biotech, Inc. (Headquarters: Shanghai, China, CEO:&nbs...

 February 10, 2026 | News

CaseBioscience Launches Cell Therapy Grade Cryopreservation And Hypothermic Storage Solutions At Advanced Therapies Week 2026

Introducing cell therapy–grade cryopreservation and hypothermic storage solutions designed for consistency, quality, and performa...

 February 10, 2026 | News

Innovent Biologics And Eli Lilly Expand Oncology And Immunology Alliance With Global Development Model

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality m...

 February 10, 2026 | News

New England Biolabs Showcases Automation Ready NGS Workflows Through Global SLAS Collaborations

New England Biolabs (NEB ®) will present several scientific posters at this week's Society for Laboratory Automation and Screening (SLAS) meeting in Bo...

 February 09, 2026 | News

China Approves Promega OncoMate MSI Companion Diagnostic For KEYTRUDA Therapy

The National Medical Products Administration (NMPA) has approved the OncoMate® Microsatellite Instability (MSI) Detection Kit as a Class III in vi...

 February 06, 2026 | News

PepLib Biotech Enters Global Peptide Drug Discovery And Licensing Collaboration With Eli Lilly

Zonsen PepLib Biotech Inc. (“PepLib”) announced that it has entered a global research and development (R&D) collaboration and license agree...

 February 06, 2026 | News

Lupin Launches Topiramate Extended Release Capsules In The United States

 Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN)  announced the launch of Topira...

 February 06, 2026 | News

Everest Medicines Secures Exclusive Asia Pacific Rights To First In Class Dual Target SHPT Therapy MT1013

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturi...

 February 06, 2026 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close